Medicare Enrolled
Dr. Don Lee, M.D.
Interventional Cardiology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Don Lee is an interventional cardiology specialist in Glendale, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 12,161 Medicare services across 6,339 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $35,382 from 56 pharmaceutical and/or device companies across 1358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in CA
$35,382 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,161
Medicare services
Top 6% in CA for interventional cardiology
6,339
Unique beneficiaries
$153
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~608 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,413 | $74 | $171 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,740 | $42 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,093 | $101 | $198 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
846 | $152 | $407 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 699 | $406 | $700 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
527 | $61 | $300 |
| External counterpulsation, per treatment session | 416 | $97 | $350 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
358 | $67 | $200 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
348 | $1,375 | $3,250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
320 | $13 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $96 | $198 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
192 | $151 | $525 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
191 | $146 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $45 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
185 | $166 | $500 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
179 | $415 | $900 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
141 | $11 | $37 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
132 | $44 | $100 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
132 | $87 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $145 | $250 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
104 | $225 | $500 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
97 | $1,585 | $5,000 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
93 | $109 | $350 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
70 | $96 | $226 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
65 | $10 | $45 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
64 | $18 | $70 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
59 | $44 | $140 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
55 | $48 | $150 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
53 | $7 | $25 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
17 | $16 | $32 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 13 | $20 | $33 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $34 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
32.6% medium
60.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,382
Total received (2018-2024)
Avg $5,055/year across 7 years
Top 18% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
1,358
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,325 (60.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14,057 (39.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,761
2023
$2,799
2022
$3,520
2021
$3,775
2020
$6,366
2019
$7,763
2018
$8,398
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lexicon Pharmaceuticals, Inc.
$491
Boehringer Ingelheim Pharmaceuticals, Inc.
$389
Novartis Pharmaceuticals Corporation
$381
Amgen Inc.
$256
Actelion Pharmaceuticals US, Inc.
$248
Esperion Therapeutics, Inc.
$204
Merck Sharp & Dohme LLC
$144
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$129
PFIZER INC.
$108
AstraZeneca Pharmaceuticals LP
$89
Medtronic, Inc.
$58
Kiniksa Pharmaceuticals International, plc
$52
Alnylam Pharmaceuticals Inc.
$39
E.R. Squibb & Sons, L.L.C.
$35
Kestra Medical Technology Services, Inc.
$30
Janssen Pharmaceuticals, Inc
$24
Lilly USA, LLC
$23
iRhythm Technologies, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$20
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 45.7% of 2024 payments
All-time payments by company (2018-2024) ›
AngioDynamics, Inc.
$13,784
Novartis Pharmaceuticals Corporation
$2,621
Amgen Inc.
$2,285
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,967
Janssen Pharmaceuticals, Inc
$1,172
AstraZeneca Pharmaceuticals LP
$1,168
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,158
E.R. Squibb & Sons, L.L.C.
$1,098
Esperion Therapeutics, Inc.
$1,055
Kowa Pharmaceuticals America, Inc.
$900
Astellas Pharma US Inc
$820
SANOFI-AVENTIS U.S. LLC
$751
PFIZER INC.
$686
Lexicon Pharmaceuticals, Inc.
$664
Merck Sharp & Dohme LLC
$656
Regeneron Healthcare Solutions, Inc.
$516
Bayer HealthCare Pharmaceuticals Inc.
$470
Actelion Pharmaceuticals US, Inc.
$454
Gilead Sciences, Inc.
$334
Alnylam Pharmaceuticals Inc.
$303
Takeda Pharmaceuticals U.S.A., Inc.
$244
Bayer Healthcare Pharmaceuticals Inc.
$196
Amarin Pharma Inc.
$189
United Therapeutics Corporation
$185
Abbott Laboratories
$165
Kestra Medical Technology Services, Inc.
$144
Medtronic, Inc.
$100
Medtronic Vascular, Inc.
$100
Novo Nordisk Inc
$94
Tactile Systems Technology Inc
$90
AbbVie, Inc.
$87
Bard Peripheral Vascular, Inc.
$87
Aegerion Pharmaceuticals, Inc.
$69
iRhythm Technologies, Inc.
$67
ABIOMED
$57
Medicure Pharma Inc.
$52
Kiniksa Pharmaceuticals International, plc
$52
Kiniksa Pharmaceuticals, Ltd.
$49
Radius Health, Inc.
$47
PORTOLA PHARMACEUTICALS, INC.
$45
Merck Sharp & Dohme Corporation
$43
Otsuka America Pharmaceutical, Inc.
$40
Bardy Diagnostics, Inc.
$39
Lilly USA, LLC
$38
Allergan Inc.
$37
Edwards Lifesciences Corporation
$24
AKRIMAX PHARMACEUTICALS, LLC
$24
Boston Scientific Corporation
$24
Arbor Pharmaceuticals, Inc.
$22
Sanofi Pasteur Inc.
$20
SANOFI PASTEUR INC.
$18
SCPHARMACEUTICALS INC.
$18
Relypsa, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$16
GlaxoSmithKline, LLC.
$12
Venclose Inc.
$8
Top 3 companies account for 52.8% of all-time payments
Associated products mentioned in payments ›
ADACEL · AMVUTTRA · ANDEXXA · ANORO · Adempas · Aimovig · Arcalyst · Assure WCD · BRILINTA · BYDUREON · BYSTOLIC · CAMZYOS · CardioMEMS HF System · Carnation Ambulatory Monitor · Circulatory Support · ClosureFast · Corlanor · Creon · ELIQUIS · ENTRESTO · EVENITY · EVKEEZA · EVLT · EVRSF · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FLUZONE HIGH-DOSE · FUROSCIX · Flexitouch Plus · HORNET · INVOKANA · Impella · Inpefa · JARDIANCE · JUXTAPID · Kerendia · LEQVIO · LEXISCAN · LIVALO · Lexiscan · LifeVest · Livalo · MOUNJARO · MOVANTIK · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RYBELSUS · Repatha · Resolute · SAMSCA · STIOLTO · SYMBICORT · Stendra · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRADJENTA · TRINTELLIX · TRULICITY · TYVASO · Tymlos · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Verquvo · WINREVAIR · XARELTO · ZIO XT Patch · ZYPITAMAG · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
99
Per 100K population
1.0
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lee performed 3,413 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $35,382 from 56 companies across 1,358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other interventional cardiologists in Glendale?
Dr. Lee's average Medicare payment per service is $153. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Glendale
Browse interventional cardiologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology